The increase in prostate cancer screening with prostate specific antigen (PSA) and digital rectal exam (DRE), and the recent development of the superior accuracy of the multiparametric prostate magnetic resonance imaging (MRI) have led to early diagnosis of clinically significant cancers and consequently reduction in morbidity and mortality due to early treatment (2, 3). The gene discussed is KLK3; the disease is cancer.